Rapid symptom relief in reflux oesophagitis: A comparison of lansoprazole and omeprazole

被引：86

作者：

Mee, AS ^{[1
]}

Rowley, JL ^{[1
]}

Adamson, A ^{[1
]}

Alderson, D ^{[1
]}

Allison, M ^{[1
]}

Bardhan, K ^{[1
]}

Beattie, A ^{[1
]}

Bell, JR ^{[1
]}

Brough, WA ^{[1
]}

Burke, D ^{[1
]}

Chapman, R ^{[1
]}

Cochrane, P ^{[1
]}

Crowe, J ^{[1
]}

Davies, P ^{[1
]}

Denyer, M ^{[1
]}

Dunk, A ^{[1
]}

Ellis, WR ^{[1
]}

Epstein, O ^{[1
]}

Finch, PJ ^{[1
]}

Gleeson, D ^{[1
]}

Hall, M ^{[1
]}

Hallissey, M ^{[1
]}

Ingoldby, C ^{[1
]}

Ireland, A ^{[1
]}

Keeling, P ^{[1
]}

Kerrigan, G ^{[1
]}

Kingston, R ^{[1
]}

LancasterSmith, M ^{[1
]}

Long, R ^{[1
]}

MacIver ^{[1
]}

McNeil, I ^{[1
]}

Miller, J ^{[1
]}

Miloszewski, K ^{[1
]}

Myszor, M ^{[1
]}

Palmer, K ^{[1
]}

Pennington, C ^{[1
]}

Polson, R ^{[1
]}

Rake, M ^{[1
]}

Reed, P ^{[1
]}

Rhodes, J ^{[1
]}

Robinson, T ^{[1
]}

Rose, J ^{[1
]}

Royston, C ^{[1
]}

Saunders, J ^{[1
]}

Saverymuttu, S ^{[1
]}

Shaffer, J ^{[1
]}

Shreeve, D ^{[1
]}

Smart, H ^{[1
]}

Tanner, A ^{[1
]}

机构：

[1] LEDERLE LABS,GOSPORT,HANTS,ENGLAND

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 1996年 / 10卷 / 05期

关键词：

D O I：

10.1046/j.1365-2036.1996.56198000.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background: Lansoprazole, a substituted benzimidazole, is a proton pump inhibitor which is highly effective in the control of 24-h intragastric acidity. The aim of this multicentre, randomized, double-blind study was to compare lansoprazole 30 mg once daily and omeprazole 20 mg once daily in the symptom relief and healing of patients with reflux oesophagitis, Methods: Six hundred and four patients with endoscopically proven oesophagitis and a recent history of heartburn were randomly assigned to receive lansoprazole 30 mg or omeprazole 20 mg daily for 4-8 weeks, Daily assessment of symptoms was made by the patient using a 100-mm Visual Analogue Scale. Clinical symptoms were evaluated at weeks 0, 1, 4 and 8. Endoscopic assessment of healing, defined by normalization of the oesophageal mucosal appearance, was made at weeks 4 and 8. Results: Two hundred and eighty-two patients in the lansoprazole group and 283 patients in the omeprazole group were eligible for inclusion in the per protocol analysis. At 3 days, there was a significant improvement in daytime symptoms of heartburn for patients in the lansoprazole group compared with the omeprazole group (P = 0.05). A similar but nonsignificant trend was seen at 7 days (P = 0.18), Clinical assessment at 7 days demonstrated significant improvement in daytime epigastric pain in the lansoprazole group compared with the omeprazole group (P = 0.03), with a similar but non-significant trend in night-time epigastric pain (P = 0.07), Healing rates of oesophagitis at 4 and 8 weeks were 70 and 87%, respectively, with lansoprazole, and 63 and 82%, respectively, with omeprazole. Logistic regression analysis of the cumulative healing rates, which included baseline factors affecting outcome, resulted in an odds ratio of 1.46 (95% CI = 0.87-2.45), suggesting a higher chance of being healed with lansoprazole treatment compared with omeprazole treatment. A total of 615 adverse events were reported by 308 (51%) patients during the study period. The majority of events were mild in nature and the incidence was similar in both treatment groups, The most frequently reported events were headache, diarrhoea and nausea, Conclusion: Lansoprazole provides greater symptom relief compared with omeprazole during the first week of treatment. Both treatments were effective in healing oesophagitis.

引用

页码：757 / 763

页数：7

共 50 条

[31] Symptom relief in symptomatic mild reflux oesophagitis: Omeprazole 20 mg om more effective than high dose ranitidine 300 mg bid
Festen, HPM
Tan, TG
Snel, P
Nelis, GF
GASTROENTEROLOGY, 1997, 112 (04) : A117 - A117
[32] The effect of treating reflux oesophagitis with omeprazole on quality of life
McDougall, NI
Collins, JSA
McFarland, RJ
Watson, RGP
Love, AHG
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1998, 10 (06) : 459 - 464
[33] Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial
Kahrilas, PJ
Falk, GW
Johnson, DA
Schmitt, C
Collins, DW
Whipple, J
D'Amico, D
Hamelin, B
Joelsson, B
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (10) : 1249 - 1258
[34] Comparative clinical GERD symptom relief with rabeprazole, lansoprazole, and omeprazole: Role of H.pylori infection
Kuwayama, H
Takahashi, M
Koizumi, K
Sakai, J
Takada, H
Oka, S
GASTROENTEROLOGY, 2003, 124 (04) : A543 - A544
[35] Mosapride as Adjunct to Lansoprazole for Symptom Relief of Reflux Esophagitis: Double-Blind Randomized Trial
Hsu, Yao-Chun
Yang, Tzeng-Huey
Hsu, Wei-Lun
Wu, Huei-Tang
Cheng, Yang-Chih
Chiang, Ming-Feng
Wang, Chaur-Shine
Lin, Hwai-Jeng
GASTROENTEROLOGY, 2010, 138 (05) : S653 - S653
[36] Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis
Jansen, JBMJ
Van Oene, JC
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (12) : 1611 - 1620
[37] Pantoprazole and omeprazole in the treatment of reflux oesophagitis: A European multicentre study
Corinaldesi, R
Valentini, M
Belaiche, J
Colin, R
Geldof, H
Maier, C
Cremer, M
Deltenre, M
Devis, G
Gillard, V
Robaeys, G
vanMaercke, Y
Costil, V
Escourrou, J
Gislon, J
Gouerou, H
Guivarch, P
Lambert, R
LeParco, J
Michel, H
Mignon, M
Rampal, P
Simon, J
DeBerardinis, F
Francavilla, A
Mazzeo, F
Minoli, G
Savarino, V
Beker, J
Dekker, C
Engels, L
Westerveld, B
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1995, 9 (06) : 667 - 671
[38] Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus
Sontag, SJ
Schnell, TG
Chejfec, G
Kurucar, C
Karpf, J
Levine, G
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) : 147 - 156
[39] Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis
Holloway, RH
Dent, J
Narielvala, F
Mackinnon, AM
GUT, 1996, 38 (05) : 649 - 654
[40] Comparison of omeprazole 10 mg and ranitidine 150 mg bid in the long term treatment of reflux oesophagitis
Festen, HPM
Tan, TG
Snel, P
Nelis, GF
GUT, 1997, 41 : A201 - A202

← 1 2 3 4 5 →